16 4
References
- Lohmeier TE, Iliescu R. The baroreflex as a long-term controller of arterial pressure.
Physiology (Bethesda). 2015;30:148–58. doi:10.1152/physiol.00035.2014. - Hall JE. Renal dysfunction, rather than nonrenal vascular dysfunction, mediates salt-induced
hypertension. Circulation. 2016;133:894–906. doi:10.1161/CIRCULATIONAHA.115.018526. - Johns EJ, Kopp UC, DiBona GF. Neural control of renal function. Compr Physiol. 2011;1:731–
67. doi:10.1002/cphy.c100043. - Iliescu R, Tudorancea I, Lohmeier TE. Baroreflex activation: from mechanisms to therapy for
cardiovascular disease. Curr Hypertens Rep. 2014;16:453. doi:10.1007/s11906-014-0453-9. - Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hyperten-
sion. Circ Res. 2015;116:976–90. doi:10.1161/CIRCRESAHA.116.303604. - Reinhart GA, Lohmeier TE, Hord CE. Hypertension induced by chronic renal adrenergic stim-
ulation is angiotensin dependent. Hypertension. 1995;25:940–9. - Lohmeier TE, Dwyer TM, Irwin ED, Rossing MA, Kieval RS. Prolonged activation of the
baroreflex abolishes obesity-induced hypertension. Hypertension. 2007;49:1307–14.
doi:10.1161/HYPERTENSIONAHA.107.087874. - Robles RG, Villa E, Santirso R, Martínez J, Ruilope LM, Cuesta C, et al. Effects of captopril
on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced
hypertension in dogs. Am J Hypertens. 1993;6:1009–15. - Grassi G, Ram VS. Evidence for a critical role of the sympathetic nervous system in hyperten-
sion. J Am Soc Hypertens. 2016;10:457–66. doi:10.1016/j.jash.2016.02.015. - Esler M. The sympathetic nervous system in hypertension: back to the future? Curr Hypertens
Rep. 2015;17:11. doi:10.1007/s11906-014-0519-8. - Esler M. The sympathetic nervous system through the ages: from Thomas Willis to resistant
hypertension. Exp Physiol. 2011;96:611–22. doi:10.1113/expphysiol.2011.052332. - Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and
heart failure. Eur Heart J. 2012;33:1058–66. doi:10.1093/eurheartj/ehs041. - Hering D, Schlaich M. The role of central nervous system mechanisms in resistant hyperten-
sion. Curr Hypertens Rep. 2015;17:58. doi:10.1007/s11906-015-0570-0. - Lohmeier TE, Lohmeier JR, Reckelhoff JF, Hildebrandt DA. Sustained influence of the renal
nerves to attenuate sodium retention in angiotensin hypertension. Am J Physiol Regul Integr
Comp Physiol. 2001;281:R434–43. - Lohmeier TE, Iliescu R. Chronic activation of the baroreflex and the promise for hypertension
therapy. Handb Clin Neurol. 2013;117:395–406. doi:10.1016/B978-0-444-53491-0.00032-8. - Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympa-
thetic nerve activity in essential and secondary hypertension. Hypertension. 1998;31:68–72. - Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension:
diagnosis, evaluation, and treatment: a scientific statement from the American Heart
Association Professional Education Committee of the Council for High Blood Pressure
Research. Circulation. 2008;117:e510–26. doi:10.1161/CIRCULATIONAHA.108.189141. - Grassi G. Sympathomodulatory effects of antihypertensive drug treatment. Am J Hypertens.
2016;29:665–75. doi:10.1093/ajh/hpw012. - Iliescu R, Irwin ED, Georgakopoulos D, Lohmeier TE. Renal responses to chronic suppression
of central sympathetic outflow. Hypertension. 2012;60:749–56. doi:10.1161/
HYPERTENSIONAHA.112.193607. - Lohmeier TE, Hildebrandt DA, Dwyer TM, Iliescu R, Irwin ED, Cates AW, et al. Prolonged
activation of the baroreflex decreases arterial pressure even during chronic adrenergic block-
ade. Hypertension. 2009;53:833–8. doi:10.1161/HYPERTENSIONAHA.109.128884. - Rao A, Pandya V, Whaley-Connell A. Obesity and insulin resistance in resistant hypertension:
implications for the kidney. Adv Chronic Kidney Dis. 2015;22:211–7. doi:10.1053/j.
ackd.2014.12.004.
R. Iliescu and D.N. Şerban